Coombs test
Coombs test | |
---|---|
MeSH | D003298 |
MedlinePlus | 003344 |
The direct and indirect Coombs tests, also known as antiglobulin test (AGT), are
The direct Coombs test is used to test for
The indirect Coombs test is used in prenatal testing of pregnant women and in testing prior to a blood transfusion. The test detects antibodies against foreign red blood cells. In this case, serum is extracted from a blood sample taken from the patient. The serum is incubated with foreign red blood cells of known antigenicity. Finally, anti-human globulin is added. If agglutination occurs, the indirect Coombs test is positive.[2]
Mechanism
The two Coombs tests are based on anti-human
Common clinical uses of the Coombs test include the preparation of blood for
Coombs tests are performed using RBCs or serum (direct or indirect, respectively) from venous whole blood samples which are taken from patients by
Direct Coombs test
The direct Coombs test, also referred to as the direct antiglobulin test (DAT), is used to detect if antibodies or complement system factors have bound to RBCs surface antigens.[5] The DAT is not required for pre-transfusion testing[6] but may be carried out by some laboratories.[clarification needed] Before transfusion, an indirect Coombs test is often done.
Uses
The direct Coombs test is used clinically when immune-mediated hemolytic anemia (antibody-mediated destruction of RBCs) is suspected. A positive Coombs test indicates that an immune mechanism is attacking the patient's RBCs. This mechanism could be autoimmunity, alloimmunity or a drug-induced immune-mediated mechanism.[3]
Examples of alloimmune hemolysis
- Hemolytic disease of the newborn (also known as HDN or erythroblastosis fetalis)
- Rh D hemolytic disease of the newborn(also known as Rh disease)
- ABO hemolytic disease of the newborn(the direct Coombs test may only be weakly positive)
- Anti-Kell hemolytic disease of the newborn
- Rh c hemolytic disease of the newborn
- Rh E hemolytic disease of the newborn
- Other blood group incompatibility (RhC, Rhe, Kidd, Duffy, Lewis, MN, P and others)
- Alloimmune hemolytic transfusion reactions
Examples of autoimmune hemolysis/immunohemolytic hemolysis
- Warm antibody autoimmune hemolytic anemia
- Idiopathic
- Systemic lupus erythematosus
- Evans' syndrome(antiplatelet antibodies and hemolytic antibodies)
- Cold antibody immunohemolytic anemia
- Idiopathic cold hemagglutinin syndrome
- Waldenström's macroglobulinemia
- Infectious mononucleosis
- Paroxysmal cold hemoglobinuria (rare)
Drug-induced immune-mediated hemolysis
- Methyldopa (IgG mediated type II hypersensitivity)
- Penicillin (high dose)
- Quinidine (IgM mediated activation of classical complement pathway and Membrane attack complex, MAC)
(A memory device to remember that the DAT tests the RBCs and is used to test infants for haemolytic disease of the newborn is: Rh Disease; R = RBCs, D = DAT.)
Laboratory
The patient's
Indirect Coombs test
The indirect Coombs test, also referred to as the indirect antiglobulin test (IAT), is used to detect
Uses
Blood transfusion preparation
The indirect Coombs test is used to screen for antibodies in the preparation of
- Antibody screening
A blood sample from the recipient and a blood sample from every unit of
- Cross matching
The indirect Coombs test is used to test a sample of the recipient's serum for antibodies against a sample of the
Antenatal antibody screening
The indirect Coombs test is used to screen pregnant women for
Laboratory method
The IAT is a two-stage test. (A cross match is shown visually in the lower half of the schematic as an example of an indirect Coombs test).[citation needed]
First stage
Nonpatient, washed
Second stage
The RBCs are washed three or four times with isotonic saline solution and then incubated with antihuman globulin. If antibodies have bound to RBC surface antigens in the first stage, RBCs will agglutinate when incubated with the antihuman globulin (also known Coombs reagent) in this stage, and the indirect Coombs test will be positive.
Titrations
By diluting a serum containing antibodies the quantity of the antibody in the serum can be gauged. This is done by performing serial dilutions of the serum and finding the maximum dilution of test serum that is able to produce agglutination of relevant RBCs.[citation needed]
Coombs reagent
Coombs reagent (also known as Coombs antiglobulin or antihuman globulin) is used in both the direct Coombs test and the indirect Coombs test. Coombs reagent is antihuman
Enhancement media
Both
History
The Coombs test was first described in 1945 by Cambridge immunologists Robin Coombs (after whom it is named), Arthur Mourant and Rob Race.[8] Historically, it was done in test tubes. Today, it is commonly done using automated solid phase or gel technology.
References
- ^ a b c "Coombs test: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2019-05-06.
- ^ F. Rosen and R. Geha, Case Studies in Immunology, 4th ed., Garland Science, p.173.
- ^ PMID 22566278.
- PMID 31613487.
- OCLC 913870019.
- ^ "13.3: Pre-transfusion testing". Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. 4 October 2023.
- ^ Image by Mikael Häggström, MD. Source for conditions: Joe Chaffin (2017-02-27). "028: Who DAT? with Sue Johnson". Citing: C Feldman & J O'Connor.
- PMID 21006651.
External links
- Coombs' test- Medlineplus.org.
- Drugs that cause haemolytic anemia - Merck Manual.
- Coombs'+Test at the U.S. National Library of Medicine Medical Subject Headings (MeSH)